CompletedNCT00835107
Ziprasidone and sleep patterns in bipolarity-related depression
About this title
Read the official source — NCT00835107Medication studyAges 18+Canada
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- KingstonSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateFebruary 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 14
- Sponsor
- Queen's University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- Over 18 Years
- Official registry ID
- NCT00835107
- Official title
Show the full official title
An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Kingston
Questions about this study
Who is behind this study?
The study sponsor is Queen's University, a university.
Did this study involve medication?
Yes. The study involved medication, including ziprasidone hydrochloride and placebo.
Who was this study for?
Listed age limits: from 18 years.
